Philippe Aftimos, MD · @aftimosp · X·· 2 天前评分70
正文 · 机器翻译
PANKU-Breast01 🇨🇳：EGFR和HER3双靶点ADC Iza-Bren与TPC在HR+/HER2-既往治疗MBC中的对比：
🔹 Iza-bren组中位PFS改善：8.2 vs 4个月（HR 0.41）
🔹 OS数据尚未成熟
🔸 Iza-bren组3级AE更多
#ESMO26 #ESMOAmbassadors
@myESMO @PTarantinoMD @E_de_Azambuja
373 浏览 · 3 赞 · 2 转发 · 0 回复
会议摘要
LBA50按 Proffered paper 1: Breast cancer, early and advanced stage 对上
PANKU-Breast01: Randomized phase III study of izalontamab brengitecan (iza-bren) in previously treated unresectable locally advanced or metastatic (LA/M) hormone receptor-positive/HER2-negative (HR+/HER2-) breast cancer (BC)
https://esmocongress.esmo.org来源：Philippe Aftimos, MD · x.com